A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment ...

Prostate cancer is the second most common form of cancer found in men worldwide, affecting one out of nine at some point in their lives. It’s also the second leading cause of cancer death among men in ...

The LynxDx leadership team. In the front row (from left to right) are: Spencer Heaton, Chief Medical and Commercial Officer; Steve Riggs, President; and Jeff Crays, Chief Technology Officer. In the ...

Early detection of prostate cancer remains a major clinical challenge due to the lack of reliable biomarkers, despite the disease being highly treatable when caught in its early stages. Now, ...

Prostate cancer is the second most common cancer in men, with over 288,000 new cases diagnosed each year. It is also one of the most curable cancers if detected early. A new imaging tool is helping ...

CENTENNIAL, Colo.-Nationally, prostate cancer is the second most common major cancer among men, and according to the North Dakota Statewide Cancer Registry, it was the most commonly occurring cancer ...

A new study from the UK has suggested a new way to “significantly” reduce prostate cancer deaths. It says that a simple, 10-minute MRI (Magnetic Resonance Imaging) scan can pick up more early-stage ...

If you or a loved one are navigating the journey of prostate cancer, you know that every decision weighs heavily. You’ve likely faced surgery or initial treatments, only to encounter the fear that ...

Prostate cancer remains the second most common form of cancer found in men worldwide and is the second leading cause of cancer death among men in the U.S. Screening for prostate cancer can help to ...